Pharma Industry
« Previous EntriesPharmaceutical Ad Spending Expected To Grow Slowly Online.
Monday, August 30th, 2010Source: DIA Daily
In its “Health Blog,” the Wall Street Journal (8/26, Hobson) reported on the relatively small amounts of advertising money that the pharmaceutical industry is expected to spend online in coming years, in part because it wants more guidance from the FDA about how rules affect such advertising. Research firm eMarketer said in a […]
US Pharmaceutical Sales Increased In 2009.
Friday, April 2nd, 2010The AP (4/2, Perrone) reports, “Growth in US sales of pharmaceuticals bounced back last year as rebates and low-cost generic drugs drove an increase in the number of prescriptions filled, according to data tracking firm IMS Health.” US drug sales “climbed 5.1 percent to $300.3 billion in 2009 after two prior years of slower growth.” […]
Drugmakers Increasingly Using Patient Testimonials To Appeal To Consumers.
Tuesday, March 2nd, 2010The Wall Street Journal (2/25, Rockoff) reports that drugmakers are increasingly trying to capitalize on trends in peer influence in drug marketing by using more patient testimonials in ads. In fact, Pfizer Inc. began running print and TV ads for its smoking-cessation drug Chantix [varenicline] that featured patient stories after focus groups showed the testimonials […]
FDA seeks to counter expansion of prescription drug ads.
Wednesday, December 9th, 2009The St. Louis Post-Dispatch (12/9, Lambrecht) reports that the Food and Drug Administration has sent “about three dozen” letters to pharmaceutical manufacturers this year, warning them about the misleading nature of their advertisements and “ordering the ads to stop.” Now, as drugmakers push for online advertising flexibility, “Congress is watching and preparing to take up […]
AARP study finds brand-name prescription prices rising.
Friday, April 17th, 2009The AP (4/16, Werner) reports that AARP’s annual study released Wednesday found that prices “of the most popular brand-name prescription drugs are on the rise,” while “prices of generic drugs are falling and more and more seniors are making the switch to generics, a trend the powerful senior citizens’ lobby hopes to encourage.” AARP also […]
« Previous Entries
